Global Medication for Hemophilia Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Medication for Hemophilia Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 Clotting Factor Replacement Therapy Drugs
  • 1.2.3 Non-Factor Therapeutic Drugs
• 1.3 Market by Application
  • 1.3.1 Global Medication for Hemophilia Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Hemophilia A
  • 1.3.3 Hemophilia B
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Medication for Hemophilia Market Perspective (2019-2030)
• 2.2 Global Medication for Hemophilia Growth Trends by Region
  • 2.2.1 Medication for Hemophilia Market Size by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Medication for Hemophilia Historic Market Size by Region (2019-2024)
  • 2.2.3 Medication for Hemophilia Forecasted Market Size by Region (2025-2030)
• 2.3 Medication for Hemophilia Market Dynamics
  • 2.3.1 Medication for Hemophilia Industry Trends
  • 2.3.2 Medication for Hemophilia Market Drivers
  • 2.3.3 Medication for Hemophilia Market Challenges
  • 2.3.4 Medication for Hemophilia Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue Medication for Hemophilia by Players
  • 3.1.1 Global Medication for Hemophilia Revenue by Players (2019-2024)
  • 3.1.2 Global Medication for Hemophilia Revenue Market Share by Players (2019-2024)
• 3.2 Global Medication for Hemophilia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of Medication for Hemophilia, Ranking by Revenue, 2022 VS 2023 VS 2024
• 3.4 Global Medication for Hemophilia Market Concentration Ratio
  • 3.4.1 Global Medication for Hemophilia Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Medication for Hemophilia Revenue in 2023
• 3.5 Global Key Players of Medication for Hemophilia Head office and Area Served
• 3.6 Global Key Players of Medication for Hemophilia, Product and Application
• 3.7 Global Key Players of Medication for Hemophilia, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Medication for Hemophilia Breakdown Data by Type

• 4.1 Global Medication for Hemophilia Historic Market Size by Type (2019-2024)
• 4.2 Global Medication for Hemophilia Forecasted Market Size by Type (2025-2030)

5 Medication for Hemophilia Breakdown Data by Application

• 5.1 Global Medication for Hemophilia Historic Market Size by Application (2019-2024)
• 5.2 Global Medication for Hemophilia Forecasted Market Size by Application (2025-2030)

6 North America

• 6.1 North America Medication for Hemophilia Market Size (2019-2030)
• 6.2 North America Medication for Hemophilia Market Size by Type
  • 6.2.1 North America Medication for Hemophilia Market Size by Type (2019-2024)
  • 6.2.2 North America Medication for Hemophilia Market Size by Type (2025-2030)
  • 6.2.3 North America Medication for Hemophilia Market Share by Type (2019-2030)
• 6.3 North America Medication for Hemophilia Market Size by Application
  • 6.3.1 North America Medication for Hemophilia Market Size by Application (2019-2024)
  • 6.3.2 North America Medication for Hemophilia Market Size by Application (2025-2030)
  • 6.3.3 North America Medication for Hemophilia Market Share by Application (2019-2030)
• 6.4 North America Medication for Hemophilia Market Size by Country
  • 6.4.1 North America Medication for Hemophilia Market Size by Country: 2019 VS 2023 VS 2030
  • 6.4.2 North America Medication for Hemophilia Market Size by Country (2019-2024)
  • 6.4.3 North America Medication for Hemophilia Market Size by Country (2025-2030)
  • 6.4.4 United States
  • 6.4.5 Canada

7 Europe

• 7.1 Europe Medication for Hemophilia Market Size (2019-2030)
• 7.2 Europe Medication for Hemophilia Market Size by Type
  • 7.2.1 Europe Medication for Hemophilia Market Size by Type (2019-2024)
  • 7.2.2 Europe Medication for Hemophilia Market Size by Type (2025-2030)
  • 7.2.3 Europe Medication for Hemophilia Market Share by Type (2019-2030)
• 7.3 Europe Medication for Hemophilia Market Size by Application
  • 7.3.1 Europe Medication for Hemophilia Market Size by Application (2019-2024)
  • 7.3.2 Europe Medication for Hemophilia Market Size by Application (2025-2030)
  • 7.3.3 Europe Medication for Hemophilia Market Share by Application (2019-2030)
• 7.4 Europe Medication for Hemophilia Market Size by Country
  • 7.4.1 Europe Medication for Hemophilia Market Size by Country: 2019 VS 2023 VS 2030
  • 7.4.2 Europe Medication for Hemophilia Market Size by Country (2019-2024)
  • 7.4.3 Europe Medication for Hemophilia Market Size by Country (2025-2030)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 China

• 8.1 China Medication for Hemophilia Market Size (2019-2030)
• 8.2 China Medication for Hemophilia Market Size by Type
  • 8.2.1 China Medication for Hemophilia Market Size by Type (2019-2024)
  • 8.2.2 China Medication for Hemophilia Market Size by Type (2025-2030)
  • 8.2.3 China Medication for Hemophilia Market Share by Type (2019-2030)
• 8.3 China Medication for Hemophilia Market Size by Application
  • 8.3.1 China Medication for Hemophilia Market Size by Application (2019-2024)
  • 8.3.2 China Medication for Hemophilia Market Size by Application (2025-2030)
  • 8.3.3 China Medication for Hemophilia Market Share by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Medication for Hemophilia Market Size (2019-2030)
• 9.2 Asia Medication for Hemophilia Market Size by Type
  • 9.2.1 Asia Medication for Hemophilia Market Size by Type (2019-2024)
  • 9.2.2 Asia Medication for Hemophilia Market Size by Type (2025-2030)
  • 9.2.3 Asia Medication for Hemophilia Market Share by Type (2019-2030)
• 9.3 Asia Medication for Hemophilia Market Size by Application
  • 9.3.1 Asia Medication for Hemophilia Market Size by Application (2019-2024)
  • 9.3.2 Asia Medication for Hemophilia Market Size by Application (2025-2030)
  • 9.3.3 Asia Medication for Hemophilia Market Share by Application (2019-2030)
• 9.4 Asia Medication for Hemophilia Market Size by Region
  • 9.4.1 Asia Medication for Hemophilia Market Size by Region: 2019 VS 2023 VS 2030
  • 9.4.2 Asia Medication for Hemophilia Market Size by Region (2019-2024)
  • 9.4.3 Asia Medication for Hemophilia Market Size by Region (2025-2030)
  • 9.4.4 Japan
  • 9.4.5 South Korea
  • 9.4.6 China Taiwan
  • 9.4.7 Southeast Asia
  • 9.4.8 India
  • 9.4.9 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America Medication for Hemophilia Market Size (2019-2030)
• 10.2 Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Type (2019-2024)
  • 10.2.2 Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Type (2025-2030)
  • 10.2.3 Middle East, Africa, and Latin America Medication for Hemophilia Market Share by Type (2019-2030)
• 10.3 Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Application (2019-2024)
  • 10.3.2 Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Application (2025-2030)
  • 10.3.3 Middle East, Africa, and Latin America Medication for Hemophilia Market Share by Application (2019-2030)
• 10.4 Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Country: 2019 VS 2023 VS 2030
  • 10.4.2 Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Country (2019-2024)
  • 10.4.3 Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Country (2025-2030)
  • 10.4.4 Brazil
  • 10.4.5 Mexico
  • 10.4.6 Turkey
  • 10.4.7 Saudi Arabia
  • 10.4.8 Israel
  • 10.4.9 GCC Countries

11 Key Players Profiles

• 11.1 Roche
  • 11.1.1 Roche Company Details
  • 11.1.2 Roche Business Overview
  • 11.1.3 Roche Medication for Hemophilia Introduction
  • 11.1.4 Roche Revenue in Medication for Hemophilia Business (2019-2024)
  • 11.1.5 Roche Recent Developments
• 11.2 Sanofi
  • 11.2.1 Sanofi Company Details
  • 11.2.2 Sanofi Business Overview
  • 11.2.3 Sanofi Medication for Hemophilia Introduction
  • 11.2.4 Sanofi Revenue in Medication for Hemophilia Business (2019-2024)
  • 11.2.5 Sanofi Recent Developments
• 11.3 BioMarin Pharmaceutical
  • 11.3.1 BioMarin Pharmaceutical Company Details
  • 11.3.2 BioMarin Pharmaceutical Business Overview
  • 11.3.3 BioMarin Pharmaceutical Medication for Hemophilia Introduction
  • 11.3.4 BioMarin Pharmaceutical Revenue in Medication for Hemophilia Business (2019-2024)
  • 11.3.5 BioMarin Pharmaceutical Recent Developments
• 11.4 Baxter
  • 11.4.1 Baxter Company Details
  • 11.4.2 Baxter Business Overview
  • 11.4.3 Baxter Medication for Hemophilia Introduction
  • 11.4.4 Baxter Revenue in Medication for Hemophilia Business (2019-2024)
  • 11.4.5 Baxter Recent Developments
• 11.5 Pfizer
  • 11.5.1 Pfizer Company Details
  • 11.5.2 Pfizer Business Overview
  • 11.5.3 Pfizer Medication for Hemophilia Introduction
  • 11.5.4 Pfizer Revenue in Medication for Hemophilia Business (2019-2024)
  • 11.5.5 Pfizer Recent Developments
• 11.6 Novo Nordisk
  • 11.6.1 Novo Nordisk Company Details
  • 11.6.2 Novo Nordisk Business Overview
  • 11.6.3 Novo Nordisk Medication for Hemophilia Introduction
  • 11.6.4 Novo Nordisk Revenue in Medication for Hemophilia Business (2019-2024)
  • 11.6.5 Novo Nordisk Recent Developments
• 11.7 Bayer
  • 11.7.1 Bayer Company Details
  • 11.7.2 Bayer Business Overview
  • 11.7.3 Bayer Medication for Hemophilia Introduction
  • 11.7.4 Bayer Revenue in Medication for Hemophilia Business (2019-2024)
  • 11.7.5 Bayer Recent Developments
• 11.8 CSL
  • 11.8.1 CSL Company Details
  • 11.8.2 CSL Business Overview
  • 11.8.3 CSL Medication for Hemophilia Introduction
  • 11.8.4 CSL Revenue in Medication for Hemophilia Business (2019-2024)
  • 11.8.5 CSL Recent Developments
• 11.9 Grifols
  • 11.9.1 Grifols Company Details
  • 11.9.2 Grifols Business Overview
  • 11.9.3 Grifols Medication for Hemophilia Introduction
  • 11.9.4 Grifols Revenue in Medication for Hemophilia Business (2019-2024)
  • 11.9.5 Grifols Recent Developments
• 11.10 Octapharma
  • 11.10.1 Octapharma Company Details
  • 11.10.2 Octapharma Business Overview
  • 11.10.3 Octapharma Medication for Hemophilia Introduction
  • 11.10.4 Octapharma Revenue in Medication for Hemophilia Business (2019-2024)
  • 11.10.5 Octapharma Recent Developments
• 11.11 BPL
  • 11.11.1 BPL Company Details
  • 11.11.2 BPL Business Overview
  • 11.11.3 BPL Medication for Hemophilia Introduction
  • 11.11.4 BPL Revenue in Medication for Hemophilia Business (2019-2024)
  • 11.11.5 BPL Recent Developments
• 11.12 Shire
  • 11.12.1 Shire Company Details
  • 11.12.2 Shire Business Overview
  • 11.12.3 Shire Medication for Hemophilia Introduction
  • 11.12.4 Shire Revenue in Medication for Hemophilia Business (2019-2024)
  • 11.12.5 Shire Recent Developments
• 11.13 uniQure
  • 11.13.1 uniQure Company Details
  • 11.13.2 uniQure Business Overview
  • 11.13.3 uniQure Medication for Hemophilia Introduction
  • 11.13.4 uniQure Revenue in Medication for Hemophilia Business (2019-2024)
  • 11.13.5 uniQure Recent Developments
• 11.14 Genentech
  • 11.14.1 Genentech Company Details
  • 11.14.2 Genentech Business Overview
  • 11.14.3 Genentech Medication for Hemophilia Introduction
  • 11.14.4 Genentech Revenue in Medication for Hemophilia Business (2019-2024)
  • 11.14.5 Genentech Recent Developments
• 11.15 CTTQ
  • 11.15.1 CTTQ Company Details
  • 11.15.2 CTTQ Business Overview
  • 11.15.3 CTTQ Medication for Hemophilia Introduction
  • 11.15.4 CTTQ Revenue in Medication for Hemophilia Business (2019-2024)
  • 11.15.5 CTTQ Recent Developments
• 11.16 Hualan Bio
  • 11.16.1 Hualan Bio Company Details
  • 11.16.2 Hualan Bio Business Overview
  • 11.16.3 Hualan Bio Medication for Hemophilia Introduction
  • 11.16.4 Hualan Bio Revenue in Medication for Hemophilia Business (2019-2024)
  • 11.16.5 Hualan Bio Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer
• 13.3 Author Details

List of Tables

• Table 1. Global Medication for Hemophilia Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
• Table 2. Key Players of Clotting Factor Replacement Therapy Drugs
• Table 3. Key Players of Non-Factor Therapeutic Drugs
• Table 4. Global Medication for Hemophilia Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
• Table 5. Global Medication for Hemophilia Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
• Table 6. Global Medication for Hemophilia Market Size by Region (2019-2024) & (US$ Million)
• Table 7. Global Medication for Hemophilia Market Share by Region (2019-2024)
• Table 8. Global Medication for Hemophilia Forecasted Market Size by Region (2025-2030) & (US$ Million)
• Table 9. Global Medication for Hemophilia Market Share by Region (2025-2030)
• Table 10. Medication for Hemophilia Market Trends
• Table 11. Medication for Hemophilia Market Drivers
• Table 12. Medication for Hemophilia Market Challenges
• Table 13. Medication for Hemophilia Market Restraints
• Table 14. Global Medication for Hemophilia Revenue by Players (2019-2024) & (US$ Million)
• Table 15. Global Medication for Hemophilia Revenue Share by Players (2019-2024)
• Table 16. Global Top Medication for Hemophilia by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medication for Hemophilia as of 2023)
• Table 17. Global Medication for Hemophilia Industry Ranking 2022 VS 2023 VS 2024
• Table 18. Global 5 Largest Players Market Share by Medication for Hemophilia Revenue (CR5 and HHI) & (2019-2024)
• Table 19. Global Key Players of Medication for Hemophilia, Headquarters and Area Served
• Table 20. Global Key Players of Medication for Hemophilia, Product and Application
• Table 21. Global Key Players of Medication for Hemophilia, Product and Application
• Table 22. Mergers & Acquisitions, Expansion Plans
• Table 23. Global Medication for Hemophilia Market Size by Type (2019-2024) & (US$ Million)
• Table 24. Global Medication for Hemophilia Revenue Market Share by Type (2019-2024)
• Table 25. Global Medication for Hemophilia Forecasted Market Size by Type (2025-2030) & (US$ Million)
• Table 26. Global Medication for Hemophilia Revenue Market Share by Type (2025-2030)
• Table 27. Global Medication for Hemophilia Market Size by Application (2019-2024) & (US$ Million)
• Table 28. Global Medication for Hemophilia Revenue Share by Application (2019-2024)
• Table 29. Global Medication for Hemophilia Forecasted Market Size by Application (2025-2030) & (US$ Million)
• Table 30. Global Medication for Hemophilia Revenue Share by Application (2025-2030)
• Table 31. North America Medication for Hemophilia Market Size by Type (2019-2024) & (US$ Million)
• Table 32. North America Medication for Hemophilia Market Size by Type (2025-2030) & (US$ Million)
• Table 33. North America Medication for Hemophilia Market Size by Application (2019-2024) & (US$ Million)
• Table 34. North America Medication for Hemophilia Market Size by Application (2025-2030) & (US$ Million)
• Table 35. North America Medication for Hemophilia Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
• Table 36. North America Medication for Hemophilia Market Size by Country (2019-2024) & (US$ Million)
• Table 37. North America Medication for Hemophilia Market Size by Country (2025-2030) & (US$ Million)
• Table 38. Europe Medication for Hemophilia Market Size by Type (2019-2024) & (US$ Million)
• Table 39. Europe Medication for Hemophilia Market Size by Type (2025-2030) & (US$ Million)
• Table 40. Europe Medication for Hemophilia Market Size by Application (2019-2024) & (US$ Million)
• Table 41. Europe Medication for Hemophilia Market Size by Application (2025-2030) & (US$ Million)
• Table 42. Europe Medication for Hemophilia Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
• Table 43. Europe Medication for Hemophilia Market Size by Country (2019-2024) & (US$ Million)
• Table 44. Europe Medication for Hemophilia Market Size by Country (2025-2030) & (US$ Million)
• Table 45. China Medication for Hemophilia Market Size by Type (2019-2024) & (US$ Million)
• Table 46. China Medication for Hemophilia Market Size by Type (2025-2030) & (US$ Million)
• Table 47. China Medication for Hemophilia Market Size by Application (2019-2024) & (US$ Million)
• Table 48. China Medication for Hemophilia Market Size by Application (2025-2030) & (US$ Million)
• Table 49. Asia Medication for Hemophilia Market Size by Type (2019-2024) & (US$ Million)
• Table 50. Asia Medication for Hemophilia Market Size by Type (2025-2030) & (US$ Million)
• Table 51. Asia Medication for Hemophilia Market Size by Application (2019-2024) & (US$ Million)
• Table 52. Asia Medication for Hemophilia Market Size by Application (2025-2030) & (US$ Million)
• Table 53. Asia Medication for Hemophilia Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
• Table 54. Asia Medication for Hemophilia Market Size by Region (2019-2024) & (US$ Million)
• Table 55. Asia Medication for Hemophilia Market Size by Region (2025-2030) & (US$ Million)
• Table 56. Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Type (2019-2024) & (US$ Million)
• Table 57. Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Type (2025-2030) & (US$ Million)
• Table 58. Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Application (2019-2024) & (US$ Million)
• Table 59. Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Application (2025-2030) & (US$ Million)
• Table 60. Middle East, Africa, and Latin America Medication for Hemophilia Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
• Table 61. Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Country (2019-2024) & (US$ Million)
• Table 62. Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Country (2025-2030) & (US$ Million)
• Table 63. Roche Company Details
• Table 64. Roche Business Overview
• Table 65. Roche Medication for Hemophilia Product
• Table 66. Roche Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
• Table 67. Roche Recent Developments
• Table 68. Sanofi Company Details
• Table 69. Sanofi Business Overview
• Table 70. Sanofi Medication for Hemophilia Product
• Table 71. Sanofi Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
• Table 72. Sanofi Recent Developments
• Table 73. BioMarin Pharmaceutical Company Details
• Table 74. BioMarin Pharmaceutical Business Overview
• Table 75. BioMarin Pharmaceutical Medication for Hemophilia Product
• Table 76. BioMarin Pharmaceutical Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
• Table 77. BioMarin Pharmaceutical Recent Developments
• Table 78. Baxter Company Details
• Table 79. Baxter Business Overview
• Table 80. Baxter Medication for Hemophilia Product
• Table 81. Baxter Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
• Table 82. Baxter Recent Developments
• Table 83. Pfizer Company Details
• Table 84. Pfizer Business Overview
• Table 85. Pfizer Medication for Hemophilia Product
• Table 86. Pfizer Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
• Table 87. Pfizer Recent Developments
• Table 88. Novo Nordisk Company Details
• Table 89. Novo Nordisk Business Overview
• Table 90. Novo Nordisk Medication for Hemophilia Product
• Table 91. Novo Nordisk Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
• Table 92. Novo Nordisk Recent Developments
• Table 93. Bayer Company Details
• Table 94. Bayer Business Overview
• Table 95. Bayer Medication for Hemophilia Product
• Table 96. Bayer Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
• Table 97. Bayer Recent Developments
• Table 98. CSL Company Details
• Table 99. CSL Business Overview
• Table 100. CSL Medication for Hemophilia Product
• Table 101. CSL Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
• Table 102. CSL Recent Developments
• Table 103. Grifols Company Details
• Table 104. Grifols Business Overview
• Table 105. Grifols Medication for Hemophilia Product
• Table 106. Grifols Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
• Table 107. Grifols Recent Developments
• Table 108. Octapharma Company Details
• Table 109. Octapharma Business Overview
• Table 110. Octapharma Medication for Hemophilia Product
• Table 111. Octapharma Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
• Table 112. Octapharma Recent Developments
• Table 113. BPL Company Details
• Table 114. BPL Business Overview
• Table 115. BPL Medication for Hemophilia Product
• Table 116. BPL Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
• Table 117. BPL Recent Developments
• Table 118. Shire Company Details
• Table 119. Shire Business Overview
• Table 120. Shire Medication for Hemophilia Product
• Table 121. Shire Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
• Table 122. Shire Recent Developments
• Table 123. uniQure Company Details
• Table 124. uniQure Business Overview
• Table 125. uniQure Medication for Hemophilia Product
• Table 126. uniQure Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
• Table 127. uniQure Recent Developments
• Table 128. Genentech Company Details
• Table 129. Genentech Business Overview
• Table 130. Genentech Medication for Hemophilia Product
• Table 131. Genentech Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
• Table 132. Genentech Recent Developments
• Table 133. CTTQ Company Details
• Table 134. CTTQ Business Overview
• Table 135. CTTQ Medication for Hemophilia Product
• Table 136. CTTQ Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
• Table 137. CTTQ Recent Developments
• Table 138. Hualan Bio Company Details
• Table 139. Hualan Bio Business Overview
• Table 140. Hualan Bio Medication for Hemophilia Product
• Table 141. Hualan Bio Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
• Table 142. Hualan Bio Recent Developments
• Table 143. Research Programs/Design for This Report
• Table 144. Key Data Information from Secondary Sources
• Table 145. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Medication for Hemophilia Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
• Figure 2. Global Medication for Hemophilia Market Share by Type: 2023 VS 2030
• Figure 3. Clotting Factor Replacement Therapy Drugs Features
• Figure 4. Non-Factor Therapeutic Drugs Features
• Figure 5. Global Medication for Hemophilia Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
• Figure 6. Global Medication for Hemophilia Market Share by Application: 2023 VS 2030
• Figure 7. Hemophilia A Case Studies
• Figure 8. Hemophilia B Case Studies
• Figure 9. Others Case Studies
• Figure 10. Medication for Hemophilia Report Years Considered
• Figure 11. Global Medication for Hemophilia Market Size (US$ Million), Year-over-Year: 2019-2030
• Figure 12. Global Medication for Hemophilia Market Size, (US$ Million), 2019 VS 2023 VS 2030
• Figure 13. Global Medication for Hemophilia Market Share by Region: 2023 VS 2030
• Figure 14. Global Medication for Hemophilia Market Share by Players in 2023
• Figure 15. Global Top Medication for Hemophilia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medication for Hemophilia as of 2023)
• Figure 16. The Top 10 and 5 Players Market Share by Medication for Hemophilia Revenue in 2023
• Figure 17. North America Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 18. North America Medication for Hemophilia Market Share by Type (2019-2030)
• Figure 19. North America Medication for Hemophilia Market Share by Application (2019-2030)
• Figure 20. North America Medication for Hemophilia Market Share by Country (2019-2030)
• Figure 21. United States Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 22. Canada Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 23. Europe Medication for Hemophilia Market Size YoY (2019-2030) & (US$ Million)
• Figure 24. Europe Medication for Hemophilia Market Share by Type (2019-2030)
• Figure 25. Europe Medication for Hemophilia Market Share by Application (2019-2030)
• Figure 26. Europe Medication for Hemophilia Market Share by Country (2019-2030)
• Figure 27. Germany Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 28. France Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 29. U.K. Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 30. Italy Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 31. Russia Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 32. Nordic Countries Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 33. China Medication for Hemophilia Market Size YoY (2019-2030) & (US$ Million)
• Figure 34. China Medication for Hemophilia Market Share by Type (2019-2030)
• Figure 35. China Medication for Hemophilia Market Share by Application (2019-2030)
• Figure 36. Asia Medication for Hemophilia Market Size YoY (2019-2030) & (US$ Million)
• Figure 37. Asia Medication for Hemophilia Market Share by Type (2019-2030)
• Figure 38. Asia Medication for Hemophilia Market Share by Application (2019-2030)
• Figure 39. Asia Medication for Hemophilia Market Share by Region (2019-2030)
• Figure 40. Japan Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 41. South Korea Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 42. China Taiwan Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 43. Southeast Asia Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 44. India Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 45. Australia Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 46. Middle East, Africa, and Latin America Medication for Hemophilia Market Size YoY (2019-2030) & (US$ Million)
• Figure 47. Middle East, Africa, and Latin America Medication for Hemophilia Market Share by Type (2019-2030)
• Figure 48. Middle East, Africa, and Latin America Medication for Hemophilia Market Share by Application (2019-2030)
• Figure 49. Middle East, Africa, and Latin America Medication for Hemophilia Market Share by Country (2019-2030)
• Figure 50. Brazil Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 51. Mexico Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 52. Turkey Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 53. Saudi Arabia Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 54. Israel Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 55. GCC Countries Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 56. Roche Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
• Figure 57. Sanofi Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
• Figure 58. BioMarin Pharmaceutical Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
• Figure 59. Baxter Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
• Figure 60. Pfizer Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
• Figure 61. Novo Nordisk Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
• Figure 62. Bayer Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
• Figure 63. CSL Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
• Figure 64. Grifols Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
• Figure 65. Octapharma Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
• Figure 66. BPL Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
• Figure 67. Shire Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
• Figure 68. uniQure Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
• Figure 69. Genentech Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
• Figure 70. CTTQ Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
• Figure 71. Hualan Bio Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
• Figure 72. Bottom-up and Top-down Approaches for This Report
• Figure 73. Data Triangulation
• Figure 74. Key Executives Interviewed